Clinical Trials Browser

Phase 2 × Panitumumab × Endocrine × Clear all

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Carcinoid Tumor, Serotonin Syndrome